Evidence map›Paper›PMID 30333507›Full record

ArticleScientific reports2018

Novel small molecules affecting cell membrane as potential therapeutics for avian pathogenic Escherichia coli.

Dipak Kathayat, Yosra A Helmy, Loic Deblais, Gireesh Rajashekara

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Microorganisms · 2025
    Review
  3. The probioticInfection and immunity · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Avian PathogenicPathogens (Basel, Switzerland) · 2021
    Review
  15. Spontaneous Phage Resistance in Avian PathogenicFrontiers in microbiology · 2021
    Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Dipak KathayatFood Animal Health Research Program, Department of Veterinary Preventive Medicine, The Ohio State University, Wooster, OH, 44691, USA.
Yosra A HelmyFood Animal Health Research Program, Department of Veterinary Preventive Medicine, The Ohio State University, Wooster, OH, 44691, USA.
Loic DeblaisFood Animal Health Research Program, Department of Veterinary Preventive Medicine, The Ohio State University, Wooster, OH, 44691, USA.
Gireesh RajashekaraFood Animal Health Research Program, Department of Veterinary Preventive Medicine, The Ohio State University, Wooster, OH, 44691, USA. rajashekara.2@osu.edu.
The Ohio State University · US

Funding

U.S. Department of Agriculture (USDA) 2015-68004-23131
6 · The paper itself

Abstract

Avian pathogenic Escherichia coli (APEC), a most common bacterial pathogen of poultry, causes multiple extra-intestinal diseases in poultry which results in significant economic losses to the poultry industry worldwide. In addition, APEC are a subgroup of extra-intestinal pathogenic E. coli (ExPEC), and APEC contaminated poultry products are a potential source of foodborne ExPEC infections to humans and transfer of antimicrobial resistant genes. The emergence of multi-drug resistant APEC strains and the limited efficacy of vaccines necessitate novel APEC control approaches. Here, we screened a small molecule (SM) library and identified 11 SMs bactericidal to APEC. The identified SMs were effective against multiple APEC serotypes, biofilm embedded APEC, antimicrobials resistant APECs, and other pathogenic E. coli strains. Microscopy revealed that these SMs affect the APEC cell membrane. Exposure of SMs to APEC revealed no resistance. Most SMs showed low toxicity towards chicken and human cells and reduced the intracellular APEC load. Treatment with most SMs extended the wax moth larval survival and reduced the intra-larval APEC load. Our studies could facilitate the development of antimicrobial therapeutics for the effective management of APEC infections in poultry as well as other E. coli related foodborne zoonosis, including APEC related ExPEC infections in humans.

Indexed as

AnimalsAnti-Bacterial AgentsBiofilmsCell MembraneChickensDrug Evaluation, PreclinicalEscherichia coliExtraintestinal Pathogenic Escherichia coliHost-Pathogen InteractionsHumansPoultryPoultry DiseasesSmall Molecule LibrariesVirulenceAnti-Bacterial AgentsSmall Molecule Libraries

Identifiers

PMID30333507
PMCPMC6193035
OpenAlexW2895892964

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.